Tang Capital Management’s Nuvation Bio NUVB Stock Holding History

Tang Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.7M	Buy	3,299,557 +150,000	+5%	+$733K	0.85%	27
2026 Q1	$13.5M	Sell	3,149,557 -707,900	-18%	-$3.94M	0.69%	28
2025 Q4	$34.6M	Sell	3,857,457 -342,543	-8%	-$2.12M	1.71%	19
2025 Q3	$15.5M	Buy	4,200,000 +300,000	+8%	+$818K	0.6%	43
2025 Q2	$7.61M	Hold	3,900,000	–	–	0.38%	65
2025 Q1	$6.86M	Hold	3,900,000	–	–	0.38%	61
2024 Q4	$10.4M	Hold	3,900,000	–	–	0.69%	40
2024 Q3	$8.93M	Buy	3,900,000 +148,136	+4%	+$452K	0.64%	46
2024 Q2	$11M	Buy	3,751,864 +200,000	+6%	+$610K	1.12%	30
2024 Q1	$12.9M	Buy	3,551,864 +51,864	+1%	+$99.6K	1.35%	23
2023 Q4	$5.29M	Buy	+3,500,000	New	+$4.5M	0.49%	51

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OFM

Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Tang Capital Management's NUVB Position: Q2 2026 in Review

Tang Capital Management increased its Nuvation Bio (NUVB) stake by 4.8% in Q2 2026, buying an estimated $733K and bringing the position to 3,299,557 shares worth $18.7M. The position accounts for 0.85% of the portfolio, ranked #27.

Tang Capital Management first reported a position in NUVB in Q4 2023 and has held it in 11 quarters since. The position peaked at $34.6M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

Tang Capital Management held 3,299,557 shares of Nuvation Bio worth $18.7M as of Q2 2026.
Tang Capital Management bought 150,000 Nuvation Bio shares in Q2 2026, an estimated $733K.
Nuvation Bio made up 0.85% of Tang Capital Management's portfolio in Q2 2026, its #27 holding.
Tang Capital Management first reported a position in Nuvation Bio in Q4 2023 and has held it in 11 quarters since.
Tang Capital Management's Nuvation Bio position peaked at $34.6M in Q4 2025.
244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.